{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T05:21:33Z","timestamp":1741324893594,"version":"3.38.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.neurol.2011.01.021","type":"journal-article","created":{"date-parts":[[2011,6,26]],"date-time":"2011-06-26T00:12:30Z","timestamp":1309047150000},"page":"65-69","source":"Crossref","is-referenced-by-count":5,"title":["Scl\u00e9rose en plaques associ\u00e9e \u00e0 un syndrome des antiphospholipides\u00a0: difficult\u00e9s diagnostiques et th\u00e9rapeutiques"],"prefix":"10.1016","volume":"168","author":[{"given":"N.","family":"Ahbeddou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Ait Ben Haddou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hammi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Slimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Regragui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Benomar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Yahyaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2011.01.021_bib0005","first-page":"482","article-title":"Primary antiphospholipid syndrome","volume":"16","author":"Alarcon-Segovia","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.neurol.2011.01.021_bib0010","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00005792-199705000-00006","article-title":"Chorea in the antiphospholipid syndrome. Clinical, radiologic and immunologic characteristics of 50\u00a0patients from our clinics and the recent literature","volume":"76","author":"Cervera","year":"1997","journal-title":"Medicine (Baltimore)"},{"issue":"5\u20136","key":"10.1016\/j.neurol.2011.01.021_bib0015","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.thromres.2004.06.016","article-title":"The interface of multiple sclerosis and antiphospholipid antibodies","volume":"114","author":"Chapman","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.neurol.2011.01.021_bib0020","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1212\/WNL.49.3.857","article-title":"Frequency and significance of antinuclear antibodies in multiple sclerosis","volume":"49","author":"Collard","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2011.01.021_bib0025","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0248-8663(99)80042-3","article-title":"Scl\u00e9rose en plaques et anticorps antiphospholipides\u00a0: \u00e9tude cons\u00e9cutive de 62\u00a0patients","volume":"19","author":"Cordoliani","year":"1998","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.neurol.2011.01.021_bib0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00005792-200001000-00006","article-title":"Can Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27\u00a0patients and review of literature","volume":"79","author":"Cuadrado","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.neurol.2011.01.021_bib0035","doi-asserted-by":"crossref","first-page":"28","DOI":"10.20452\/pamw.262","article-title":"Multiple sclerosis and antiphospholipid syndrome-difficulties in differential diagnostics","volume":"117","author":"Cz\u0142onkowska","year":"2007","journal-title":"Pol Arch Med Wewn"},{"issue":"4","key":"10.1016\/j.neurol.2011.01.021_bib0040","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/rheumatology\/keh532","article-title":"Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand?","volume":"44","author":"Ferreira","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.neurol.2011.01.021_bib0045","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1600-0404.1993.tb04214.x","article-title":"Anticardiolipin Antibodies in japanese patients with multiple sclerosis","volume":"88","author":"Fukazawa","year":"1993","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.neurol.2011.01.021_bib0050","first-page":"290","article-title":"Visual function in patients with optic neuritis associated with acute transverse myelopathy in multiple sclerosis","volume":"39","author":"Harada","year":"1995","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.neurol.2011.01.021_bib0055","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/pmj.79.928.81","article-title":"Migraine, memory loss, and \u201cmultiple sclerosis\u201d. Neurological features of the antiphospholipid (Hughes\u2019) syndrome","volume":"79","author":"Hughes","year":"2003","journal-title":"Postgraduate Med J"},{"key":"10.1016\/j.neurol.2011.01.021_bib0060","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1191\/1352458505ms1208oa","article-title":"A comparative audit of anticardiolipin antibodies in oligoclonal band Negative and positive multiple sclerosis","volume":"11","author":"Vilisaar","year":"2005","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2011.01.021_bib0065","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update classification criterion for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.neurol.2011.01.021_bib0070","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/jaut.2000.0367","article-title":"Prevalence and clinical significance of antiphspholipid antibodies in multiple sclerosis: A study of 89\u00a0patients","volume":"14","author":"Roussel","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1016\/j.neurol.2011.01.021_bib0075","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ana.81","article-title":"Anticardiolipin antibodies are not a useful screening tool in a nonselected large group of patients with multiple sclerosis","volume":"49","author":"Sastre Garriga","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2011.01.021_bib0080","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1001\/archinte.1994.00420080127013","article-title":"Antiphospholipid antibody syndrome mimicking multiple sclerosis clinically and by magnetic resonance imaging","volume":"154","author":"Scott","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.neurol.2011.01.021_bib0085","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1191\/096120398678920235","article-title":"Multiple sclerosis-like picture in association with Hughes syndrome","volume":"7","author":"Siam","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.neurol.2011.01.021_bib0090","unstructured":"Spirin NN, Pizova NV, Stepanov IO. Antiphospholipid syndrome and multiple sclerosis: differential-diagnostic aspects. Zh Nevrol Psikhiatr Im S S Korsakova 2002:42\u20135."},{"issue":"1","key":"10.1016\/j.neurol.2011.01.021_bib0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00415-009-5264-6","article-title":"MRI characteristics of patients with antiphospholipid syndrome and multiple sclerosis","volume":"257","author":"Stosic","year":"2010","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2011.01.021_bib0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0002-9343(97)90046-2","article-title":"Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy","volume":"103","author":"Verrot","year":"1997","journal-title":"Am J Med"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378711002359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378711002359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T18:18:40Z","timestamp":1741285120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378711002359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0035378711002359"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2011.01.021","relation":{},"ISSN":["0035-3787"],"issn-type":[{"type":"print","value":"0035-3787"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}